SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001341004-23-000191
Filing Date
2023-08-24
Accepted
2023-08-24 16:26:06
Documents
3
Group Members
CFIP CLYD LLCFIG CORP.FIG LLCFIP FUND II GP LLCFIP II UB INVESTMENTS LPFORTRESS OPERATING ENTITY I LPHYBRID GP HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 1 sc13da1.htm SC 13D/A 193681
2 EXHIBIT 4 - SUBSCRIPTION AGREEMENT ex4.htm EX-99.4 276090
3 EXHIBIT 5 - FORM OF AMENDED AND RESTATED SHAREHOLDERS' RIGHTS AGREEMENT ex5.htm EX-99.5 305700
  Complete submission text file 0001341004-23-000191.txt   777593
Mailing Address 1345 AVENUE OF THE AMERICAS 46TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 46TH FLOOR NEW YORK NY 10105 212-798-6100
Fortress Investment Group LLC (Filed by) CIK: 0001380393 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Subject) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90813 | Film No.: 231202506
SIC: 2834 Pharmaceutical Preparations